The health care industry has dramatically increased its federal lobbying under President Trump, and it has paid off for those companies.

Why it matters: The influence economy has only gotten bigger over the past three years, despite Trump’s calls to “drain the swamp.” Lobbying expenses have soared, and in the process, the health care industry has largely gotten what it wanted in Washington…

Lobbying among these 60 groups soared 10% in 2017. Spending then grew more slowly in 2018, before jumping another 9% this past year.

The pharmaceutical industry — and specifically its main trade group, PhRMA — have spent the most money by far on lobbying under Trump, as both he and Democrats have called out the industry’s pricing tactics.